Supernus Pharmaceuticals Inc (SUPN)
30.24
+0.18
(+0.60%)
USD |
NASDAQ |
May 02, 16:00
30.24
0.00 (0.00%)
After-Hours: 16:27
Supernus Pharmaceuticals Cash and Short Term Investments (Quarterly): 254.87M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 254.87M |
| September 30, 2023 | 200.19M |
| June 30, 2023 | 151.66M |
| March 31, 2023 | 228.57M |
| December 31, 2022 | 461.33M |
| September 30, 2022 | 391.79M |
| June 30, 2022 | 360.79M |
| March 31, 2022 | 312.20M |
| December 31, 2021 | 339.68M |
| September 30, 2021 | 443.85M |
| June 30, 2021 | 409.84M |
| March 31, 2021 | 391.10M |
| December 31, 2020 | 422.53M |
| September 30, 2020 | 351.95M |
| June 30, 2020 | 374.81M |
| March 31, 2020 | 400.87M |
| December 31, 2019 | 347.07M |
| September 30, 2019 | 296.70M |
| June 30, 2019 | 258.57M |
| March 31, 2019 | 292.94M |
| December 31, 2018 | 356.02M |
| September 30, 2018 | 280.22M |
| June 30, 2018 | 174.41M |
| March 31, 2018 | 489.72M |
| December 31, 2017 | 140.04M |
| Date | Value |
|---|---|
| September 30, 2017 | 114.55M |
| June 30, 2017 | 92.97M |
| March 31, 2017 | 87.13M |
| December 31, 2016 | 90.12M |
| September 30, 2016 | 80.33M |
| June 30, 2016 | 60.21M |
| March 31, 2016 | 45.26M |
| December 31, 2015 | 62.19M |
| September 30, 2015 | 57.70M |
| June 30, 2015 | 69.79M |
| March 31, 2015 | 64.84M |
| December 31, 2014 | 74.34M |
| September 30, 2014 | 72.56M |
| June 30, 2014 | 47.27M |
| March 31, 2014 | 58.87M |
| December 31, 2013 | 82.19M |
| September 30, 2013 | 87.24M |
| June 30, 2013 | 102.63M |
| March 31, 2013 | 69.89M |
| December 31, 2012 | 88.51M |
| September 30, 2012 | 60.94M |
| June 30, 2012 | 76.65M |
| March 31, 2012 | 37.38M |
| December 31, 2011 | 48.54M |
| September 30, 2011 | 16.48M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
151.66M
Minimum
Jun 2023
461.33M
Maximum
Dec 2022
336.76M
Average
351.95M
Median
Sep 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Dynavax Technologies Corp | 742.30M |
| Ligand Pharmaceuticals Inc | 170.31M |
| Pacira BioSciences Inc | 278.58M |
| Esperion Therapeutics Inc | 82.25M |
| Collegium Pharmaceutical Inc | 310.55M |